UYOVBO ANTHONY: Open Payments
NPI 1770174856 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,554 in 80 payments from 17 companies in 2025. Trend: 2023 $683 · 2024 $956 · 2025 $1,554
Food & beverage: $1,554
| Company | Payments | Amount |
|---|---|---|
| Corium, LLC | 15 | $299 |
| Alkermes, Inc. | 12 | $166 |
| Janssen Pharmaceuticals, Inc | 9 | $165 |
| Lundbeck LLC | 7 | $148 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $119 |
| Teva Pharmaceuticals USA, Inc. | 3 | $96 |
| ABBVIE INC. | 4 | $74 |
| Neurocrine BioSciences, Inc. | 3 | $73 |
| Collegium Pharmaceutical, Inc. | 4 | $66 |
| Supernus Pharmaceuticals, Inc. | 3 | $57 |
Products named: Azstarys, REXULTI, LYBALVI, TRINTELLIX, INVEGA SUSTENNA, AUSTEDO XR, VRAYLAR, INGREZZA.
Industry payments across TX — which companies pay providers there.
